AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis

被引:0
|
作者
Xiaojiang Gao
Arman Bashirova
Astrid K N Iversen
John Phair
James J Goedert
Susan Buchbinder
Keith Hoots
David Vlahov
Marcus Altfeld
Stephen J O'Brien
Mary Carrington
机构
[1] Laboratory of Genomic Diversity,Division of Cancer Epidemiology and Genetics
[2] NCI-Frederick,undefined
[3] Basic Research Program,undefined
[4] SAIC Frederick,undefined
[5] P.O. Box B,undefined
[6] Johns Hopkins University School of Medicine,undefined
[7] MRC Human Immunology Unit,undefined
[8] Weatherall Institute of Molecular Medicine,undefined
[9] University of Oxford,undefined
[10] John Radcliffe Hospital,undefined
[11] Howard Brown Health Center and The Fineberg School of Medicine,undefined
[12] Northwestern University,undefined
[13] Viral Epidemiology Branch,undefined
[14] National Cancer Institute,undefined
[15] San Francisco Department of Public Health,undefined
[16] Gulf States Hemophilia Center,undefined
[17] University of Texas Health Science Center,undefined
[18] Center for Urban Epidemiologic Studies,undefined
[19] New York Academy of Medicine,undefined
[20] Partners AIDS Research Center,undefined
[21] Massachusetts General Hospital,undefined
[22] Laboratory of Genomic Diversity,undefined
[23] National Cancer Institute,undefined
[24] P.O. Box B,undefined
[25] Building 560,undefined
来源
Nature Medicine | 2005年 / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
An effective acquired immune response to infectious agents mediated by HLA-restricted T-cell recognition can target different stages of disease pathogenesis. We show here that three distinct HLA alleles known to alter the overall rate of AIDS progression act during distinct intervals after HIV-1 infection. The discrete timing of HLA allele influence suggests alternative functional mechanisms in immune defense against this dynamic and chronic immunosuppressive disease.
引用
收藏
页码:1290 / 1292
页数:2
相关论文
共 50 条
  • [1] AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis
    Gao, X
    Bashirova, A
    Iversen, AN
    Phair, J
    Goedert, JJ
    Buchbinder, S
    Hoots, K
    Vlahov, D
    Altfeld, M
    O'Brien, SJ
    Carrington, M
    [J]. TISSUE ANTIGENS, 2005, 66 (05): : 424 - 424
  • [2] AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis
    Gao, XJ
    Bashirova, A
    Iversen, AKN
    Phair, J
    Goedert, JJ
    Buchbinder, S
    Hoots, K
    Vlahov, D
    Altfeld, M
    O'Brien, SJ
    Carrington, M
    [J]. NATURE MEDICINE, 2005, 11 (12) : 1290 - 1292
  • [3] HLA MIMICRY BY HIV-1 GP120 IN THE PATHOGENESIS OF AIDS
    HABESHAW, JA
    [J]. IMMUNOLOGY TODAY, 1994, 15 (01): : 39 - 40
  • [4] HIV-1 Tat and Immune Dysregulation in AIDS Pathogenesis: A Therapeutic Target
    Chiozzini, Chiara
    Toschi, Elena
    [J]. CURRENT DRUG TARGETS, 2016, 17 (01) : 33 - 45
  • [5] Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10
    Shin, HD
    Winkler, C
    Stephens, JC
    Bream, J
    Young, H
    Goedert, JJ
    O'Brien, TR
    Vlahov, D
    Buchbinder, S
    Giorgi, J
    Rinaldo, C
    Donfield, S
    Willoughby, A
    O'Brien, SJ
    Smith, MW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) : 14467 - 14472
  • [6] HOST AND HIV-1 VARIATION IN AIDS PATHOGENESIS
    EDWARDS, M
    JIAHSU, Y
    NGUYEN, P
    TRISTAN, M
    PIZZUTI, A
    CLEMENS, P
    BURGER, H
    WEISER, B
    GIBBS, R
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 406 - 406
  • [7] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS
    DEBOUCK, C
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164
  • [8] ROLE OF HIV-1 BIOLOGICAL VARIABILITY IN THE PATHOGENESIS OF AIDS
    TERSMETTE, M
    SCHUITEMAKER, H
    GROENINK, M
    KOOT, M
    KEET, R
    SCHELLEKENS, PTA
    HUISMAN, JG
    MIEDEMA, F
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 313 - 313
  • [9] HIV-1 integrase:: the next target for AIDS therapy?
    d'Angelo, J
    Mouscadet, JF
    Desmaële, D
    Zouhiri, F
    Leh, H
    [J]. PATHOLOGIE BIOLOGIE, 2001, 49 (03): : 237 - 246
  • [10] HIV-1 integrase: A target for new AIDS chemotherapeutics
    Anthony, NJ
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) : 979 - 990